Submit Your Feeds

Business News • PR NewsWire • Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients

Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients
Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients

PARIS, October 15, 2010 /PRNewswire-FirstCall/ -- - Phase III TEMSO Study Meets Goals Including Delayed Disability Progression for Teriflunomide 14mg Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the results from the two year phase III TEMSO study of teriflunomide, a no

View More : http://www.prnewswire.com/news-releases/teriflunomide-successfully-reduces-relapses-and-is-well-tolerated-in-multiple-sc...
Releted News by prnewswire
IndiaMART.com Provides Global Stage to SMEs
Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients
Cheetah Medical Announces European Launch of a New NICOM(R) System for Advanced Noninvasive Hemodynamic Monitoring and Fluid Management
Winning a Jackpot Can Bring Good Health
The Conference Board Leading Economic Index® (LEI) for Spain Increases
Home Sitemap Contact Us
© businessNewsNewsNews.com